| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 6 | |
| #2 | Japan | 3 | |
| #3 | United States | 3 | |
| #4 | Canada | 2 | |
| #5 | EPO (European Patent Office) | 2 | |
| #6 | Republic of Korea | 2 | |
| #7 | WIPO (World Intellectual Property Organization) | 2 | |
| #8 | Brazil | 1 | |
| #9 | China | 1 | |
| #10 | Colombia | 1 | |
| #11 | Israel | 1 | |
| #12 | Jordan | 1 | |
| #13 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Kim Kaman C | 11 |
| #2 | Landgraf Kyle E | 10 |
| #3 | Martin David W | 7 |
| #4 | Landgraf Kyle | 7 |
| #5 | Williams Steven R | 7 |
| #6 | Gebhart Dana | 5 |
| #7 | Steiger Daniel P | 5 |
| #8 | Baron Tarah | 5 |
| #9 | Steven R Williams | 3 |
| #10 | Daniel P Steiger | 3 |
| Publication | Filing date | Title |
|---|---|---|
| US2020239541A1 | Modified non-natural nkg2d ligands that selectively deliver attached heterologous molecules to non-natural nkg2d receptors on car-cells | |
| US2020138866A1 | Non-natural nkg2d receptors that do not directly signal the cells to which they are attached | |
| CN112074532A | Modified alpha 1-alpha 2 domains of non-natural NKG2D ligands that bind non-natural NKG2D receptors | |
| AU2016410294A1 | Insertable variable fragments of antibodies and modified a1-a2 domains of NKG2D ligands | |
| AU2015357578A1 | Insertable variable fragments of antibodies and modified a1-a2 domains of NKG2D ligands | |
| AU2011353115A1 | Non-natural MIC proteins |